Author: SkinVision Team
-
Sonographer used smartphone to find three skin cancers in her family
By cross-referencing the results of the SkinVision app with ultrasound, Bridget Sparks is turning sonographers into a frontline tool to fight the disease that threatens the lives of over 80,000 New Zealanders every single year.
-
Melanoma: The current situation in New Zealand
New Zealand has, together with Australia, the highest melanoma incidence in the world. The combination of skin type and UV impact from the sun put the inhibitors of New Zealand at high risk. So let’s take a closer look at the current melanoma situation in NZ.
-
Sun Safety Australia: Fitness and Sports Enthusiasts
Summer is here in Australia when many people will spend time outdoors playing sports and enjoying the sun. With the warm climate, beautiful beaches and wide-open space, the country is meant to be enjoyed this way.
-
Why is skin cancer so common in Australia?
Australia has a confluence of factors that put the population at risk of skin cancer. According to Cancer Council Australia, there are more than 750,000 people treated for one or more non-melanomas in Australia each year. Currently, two in three Australians will be diagnosed with some form of skin cancer before the age of 70.…
-
Milestone for SkinVision: Three Important Certifications Achieved
SkinVision, the leading app for early skin cancer detection, recently achieved three important ISO certifications. The British Standards Institution (BSI), awarded SkinVision ISO 13485:2016 for its quality management system. Additionally, BSI awarded the company ISO 27001:2013 for information security management, as well as the Dutch national standard NEN 7510:2017, which includes additional requirements to ISO…
-
New Study Finds SkinVision Detects 95% of Skin Cancer
Amsterdam, 12 September 2019 – An international group of researchers working with Erasmus University Medical Center (Erasmus MC) in the Netherlands determined that SkinVision – the first CE-marked skin cancer application based on extensive clinical trials – has a sensitivity of 95.1% in detecting the most common forms of skin cancer.
-
SkinVision Joins the DigitalHealth.London Accelerator
Smartphone App for Skin Cancer Risk Selected to Join DigitalHealth.London Accelerator SkinVision, a mobile application driving early skin cancer detection by empowering individuals to monitor their skin for early signs of skin cancer, has been selected to join the DigitalHealth.London Accelerator.
-
Press Release: 3.6M CZ policyholders offered the SkinVision Service
Dutch Health Insurer CZ and SkinVision partner to create an impact in early skin cancer detection
-
SkinVision to Join NHS Innovation Accelerator
App empowering people to monitor themselves for early signs of skin cancer selected to join NHS Innovation Accelerator SkinVision, An app which empowers people to monitor themselves for early signs of skin cancer is one of four new technologies supporting earlier diagnosis and prevention of cancer, selected to join the NHS Innovation Accelerator.
-
What is the Chickenpox Vaccine?
The vast majority of you reading this article, whether you remember it or not, will have gone through the itchy agony of chickenpox. Many of us have been left with scars from spots our parents couldn’t quite stop us itching, but not all children and parents today need to experience chickenpox distress. This is due…
